| 4002 | A | 207211 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MACLEODS PHARMS LTD | EQ 30MG BASE | AB | ["AB"] | 2017-09-14 | Sep 14, 2017 | No | No | No | RX | MACLEODS PHARMACEUTICALS LTD | 046daa298a14a45b660c8cd7ced59e96455f563ba5731a53a3440d0c13c8089b |
| 4003 | A | 207211 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MACLEODS PHARMS LTD | EQ 45MG BASE | AB | ["AB"] | 2017-09-14 | Sep 14, 2017 | No | No | No | RX | MACLEODS PHARMACEUTICALS LTD | a7f69a6fc0b0b51029c79c085204e6e7f7c63abdc3e43ec014ff69c04b97f710 |
| 4004 | A | 207211 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MACLEODS PHARMS LTD | EQ 75MG BASE | AB | ["AB"] | 2017-09-14 | Sep 14, 2017 | No | No | No | RX | MACLEODS PHARMACEUTICALS LTD | 0052e115472673f4766718804c88041a1e3865600a161e72558b54991a72f650 |
| 4005 | A | 212544 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MSN | EQ 30MG BASE | AB | ["AB"] | 2020-05-20 | May 20, 2020 | No | No | No | RX | MSN LABORATORIES PRIVATE LTD | 0037921a33ea5cfe48f6065668b9fd0e76f171775bcf1a9a0d827b5075956987 |
| 4006 | A | 212544 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MSN | EQ 45MG BASE | AB | ["AB"] | 2020-05-20 | May 20, 2020 | No | No | No | RX | MSN LABORATORIES PRIVATE LTD | 8a48dddb780b5423aaa9970de7993c3fc1b459438a5ebf16ddf44f8aabdaab97 |
| 4007 | A | 212544 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MSN | EQ 75MG BASE | AB | ["AB"] | 2020-05-20 | May 20, 2020 | No | No | No | RX | MSN LABORATORIES PRIVATE LTD | dd428a5221b5ee78b531053266efdadbb4088126aa64ad07fb9fd3ba8d837f14 |
| 4008 | A | 210157 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MYLAN | EQ 30MG BASE | | [] | 2021-01-21 | Jan 21, 2021 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 28ca8eb8159d7fbb6cb769e79beb314b4d6eb673ba279c347878f8b1c6643e1b |
| 4009 | A | 210157 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MYLAN | EQ 45MG BASE | | [] | 2021-01-21 | Jan 21, 2021 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | c3a2eba851cddb0affef348add339e6f456a40ebd2eba9077dc440fbd60ee77d |
| 4010 | A | 210157 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | MYLAN | EQ 75MG BASE | | [] | 2021-01-21 | Jan 21, 2021 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 9d92e867a313bd06b53f70385afeeec54fd062e8174947d50607e991f90afcc3 |
| 4011 | A | 202595 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NATCO PHARMA LTD | EQ 30MG BASE | AB | ["AB"] | 2016-08-03 | Aug 3, 2016 | No | No | No | RX | NATCO PHARMA LTD | 64d8da9f6b47308d1368b3d3678780f452dd7889ef7e611a6639cb4019a113cd |
| 4012 | A | 202595 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NATCO PHARMA LTD | EQ 45MG BASE | AB | ["AB"] | 2016-08-03 | Aug 3, 2016 | No | No | No | RX | NATCO PHARMA LTD | 147df6fed7697419bc9bd3a95a0410b38379b953ba3449343f4b280432dbf02c |
| 4013 | A | 202595 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NATCO PHARMA LTD | EQ 75MG BASE | AB | ["AB"] | 2016-08-03 | Aug 3, 2016 | No | No | No | RX | NATCO PHARMA LTD | b8c3a86301b4f87464c07211b1969a60ac14f8de5a7032a8c4ebd4594baf314d |
| 4014 | A | 208578 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NESHER PHARMS | EQ 30MG BASE | AB | ["AB"] | 2017-02-24 | Feb 24, 2017 | No | No | No | RX | NESHER PHARMACEUTICALS USA LLC | f0ba29f3bf427e2a61cacd54d67d94f0e977f4cd63fc6b490b309831a028c167 |
| 4015 | A | 208578 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NESHER PHARMS | EQ 45MG BASE | AB | ["AB"] | 2017-02-24 | Feb 24, 2017 | No | No | No | RX | NESHER PHARMACEUTICALS USA LLC | 958e52efd86bf07f5cd4e9be5da8dfff7319ad64660b536fd8916b706ce4fa10 |
| 4016 | A | 208578 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | NESHER PHARMS | EQ 75MG BASE | AB | ["AB"] | 2017-02-24 | Feb 24, 2017 | No | No | No | RX | NESHER PHARMACEUTICALS USA LLC | 1e269dd8848efe14b74921f47a17566d0cba0b003a61a7ea944f3cf2127a6e99 |
| 4017 | A | 209421 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | STRIDES PHARMA | EQ 30MG BASE | AB | ["AB"] | 2018-06-08 | Jun 8, 2018 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 1229fbef5bbffd1198680d7e266569eecf0bb811893b13fa8a813226e9770d79 |
| 4018 | A | 209421 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | STRIDES PHARMA | EQ 45MG BASE | AB | ["AB"] | 2018-06-08 | Jun 8, 2018 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 5b8ad643de38ddc45440c930d2cdacc586f405fa34ddfdaf1ce31954334e991b |
| 4019 | A | 209421 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | STRIDES PHARMA | EQ 75MG BASE | AB | ["AB"] | 2018-06-08 | Jun 8, 2018 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | d9f1218af2ee9152a28a24649f9a7db4095f71fa8378d0e42377ef506db28929 |
| 4020 | A | 212739 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | SUNSHINE | EQ 30MG BASE | | [] | 2020-03-04 | Mar 4, 2020 | No | No | No | DISCN | SUNSHINE LAKE PHARMA CO LTD | ba1ddffbedd845a626ee3badc86d2cd3e20a35486a46f62491d2d2e537b016f7 |
| 4021 | A | 212739 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | SUNSHINE | EQ 45MG BASE | | [] | 2020-03-04 | Mar 4, 2020 | No | No | No | DISCN | SUNSHINE LAKE PHARMA CO LTD | fac9bfb4e02961f5eb139063f5e0717647dc15c20b4fb6af58efa55625e9e254 |
| 4022 | A | 212739 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | OSELTAMIVIR PHOSPHATE | SUNSHINE | EQ 75MG BASE | | [] | 2020-03-04 | Mar 4, 2020 | No | No | No | DISCN | SUNSHINE LAKE PHARMA CO LTD | 46f4dd9b6bb6bbdcdbee805af609b2dea8ea71f9421dfa5d63574b6003d16a21 |
| 4023 | A | 062222 | 001 | OXACILLIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | OXACILLIN SODIUM | ANI PHARMS INC | EQ 250MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ANI PHARMACEUTICALS INC | 814c306f3ebfeb56ef415605ffcf88708e160ea4948e98627a3309b44d02419e |
| 4024 | A | 062222 | 002 | OXACILLIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | OXACILLIN SODIUM | ANI PHARMS INC | EQ 500MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ANI PHARMACEUTICALS INC | e7e1c9a00e95e139e1fc69472abda65d2ee0a1e0ab16a1c066acbf9d10fe2db2 |
| 4025 | A | 061450 | 002 | OXACILLIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | OXACILLIN SODIUM | APOTHECON | EQ 250MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 5826f7e35155defab37dd5c9d6dd6bf665dced0f62f814da9c8cec57d5083193 |
| 4026 | A | 061450 | 001 | OXACILLIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | OXACILLIN SODIUM | APOTHECON | EQ 500MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | c4ba17068b943dbb77d773c5fcb59e7a1ae931644b2a2d7ef93b4b9bedcfbcfb |
| 4027 | A | 072253 | 002 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | ACTAVIS ELIZABETH | 10MG | AB | ["AB"] | 1988-04-14 | Apr 14, 1988 | No | No | No | RX | ACTAVIS ELIZABETH LLC | 7a17ee50b8aeda42f3dca26e95d123eddc956698a8bb2255dffa4c20c6b21f35 |
| 4028 | A | 072253 | 003 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | ACTAVIS ELIZABETH | 15MG | AB | ["AB"] | 1988-04-14 | Apr 14, 1988 | No | No | No | RX | ACTAVIS ELIZABETH LLC | 75a86768212de8134f8f18313b0da0941db5f795e7b50342805a68d5ba4f54e8 |
| 4029 | A | 072253 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | ACTAVIS ELIZABETH | 30MG | AB | ["AB"] | 1988-04-14 | Apr 14, 1988 | No | No | Yes | RX | ACTAVIS ELIZABETH LLC | b1130e9c52912c4bce0f0e3012a5736560328099db18f5ae751021fc3ddeb691 |
| 4030 | A | 071955 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | AM THERAP | 10MG | | [] | 1988-03-03 | Mar 3, 1988 | No | No | No | DISCN | AMERICAN THERAPEUTICS INC | fa7cd507c667ac65b0df637de05acf56a19580d10a969c1d337400fa47bee79b |
| 4031 | A | 071956 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | AM THERAP | 15MG | | [] | 1988-03-03 | Mar 3, 1988 | No | No | No | DISCN | AMERICAN THERAPEUTICS INC | 40af604cac4119ed13bcdbf13e83edcb5db1983033b7ee2e5377f9a099654edf |
| 4032 | A | 071957 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | AM THERAP | 30MG | | [] | 1988-03-03 | Mar 3, 1988 | No | No | No | DISCN | AMERICAN THERAPEUTICS INC | e73ecb1ea4630617bb4d8c5e6d2dbaef6df6fd3a2385a0af9b12f0e05183e049 |
| 4033 | A | 071026 | 002 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | FRONTIDA BIOPHARM | 10MG | AB | ["AB"] | 1987-08-10 | Aug 10, 1987 | No | No | No | RX | FRONTIDA BIOPHARM INC | ae1abbf0f2f796ebe4cde7ab08752363f8c73de2a929f5ff8a487d20eedb87d4 |
| 4034 | A | 071026 | 003 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | FRONTIDA BIOPHARM | 15MG | AB | ["AB"] | 1987-08-10 | Aug 10, 1987 | No | No | No | RX | FRONTIDA BIOPHARM INC | 943d96806a66eac468750c2b8221e90327eda970e898c514b3c402c9ee3fc883 |
| 4035 | A | 071026 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | FRONTIDA BIOPHARM | 30MG | AB | ["AB"] | 1987-08-10 | Aug 10, 1987 | No | No | No | RX | FRONTIDA BIOPHARM INC | 9f726b4d83e54a8b98e53677c1d2562015efc4323ed0bbafb649708235dbc23f |
| 4036 | A | 070943 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | IVAX SUB TEVA PHARMS | 10MG | | [] | 1987-08-03 | Aug 3, 1987 | No | No | No | DISCN | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA | 407d5c75044cbfa6234cce57f35d648600b3b0f6f73d952ceb97cffdb3b24263 |
| 4037 | A | 070944 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | IVAX SUB TEVA PHARMS | 15MG | | [] | 1987-08-03 | Aug 3, 1987 | No | No | No | DISCN | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA | f4a0e8395e048db62fdce510762e1a07d2b450ee627ed4f230e746001b81dd41 |
| 4038 | A | 070945 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | IVAX SUB TEVA PHARMS | 30MG | | [] | 1987-08-03 | Aug 3, 1987 | No | No | No | DISCN | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA | 6f5195e0a1d765445a5fadbf3eedc1db3ee99270d13b4f1097feabdd76266439 |
| 4039 | A | 071713 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | MYLAN | 10MG | | [] | 1987-10-20 | Oct 20, 1987 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 285cc1269f0841f9b7ceac61531b37991e3be60c3202ffd3a22a64756004aed5 |
| 4040 | A | 071714 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | MYLAN | 15MG | | [] | 1987-10-20 | Oct 20, 1987 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | d953efd54ac4135a60b1e8ffcbb1b3e4fd5e7b2ee2f1fbb7d397be854a5bdf40 |
| 4041 | A | 071715 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | MYLAN | 30MG | | [] | 1987-10-20 | Oct 20, 1987 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 4f8c3c039b6209c8a4c0a60444e33cb01537fd11ae7538f13b780999f71908ae |
| 4042 | A | 071813 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | SANDOZ | 10MG | AB | ["AB"] | 1988-04-19 | Apr 19, 1988 | No | No | No | RX | SANDOZ INC | ae93b826b22f013b47e13332c16e5d8985aa863a9bb0c9e8b69b26900299793f |
| 4043 | A | 071756 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | SANDOZ | 15MG | AB | ["AB"] | 1988-04-19 | Apr 19, 1988 | No | No | No | RX | SANDOZ INC | 5fd55f0366061422ab52804e6034a8177b2f118e2ca37bde39dd30c835393646 |
| 4044 | A | 071814 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | SANDOZ | 30MG | AB | ["AB"] | 1988-04-19 | Apr 19, 1988 | No | No | No | RX | SANDOZ INC | 863d8ec974992b85a39f485cb6387b6ae69ed145f675e4c9c06ffc55c474c94e |
| 4045 | A | 072953 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | WATSON LABS | 15MG | | [] | 1990-09-28 | Sep 28, 1990 | No | No | No | DISCN | WATSON LABORATORIES INC | 2a92b38eca0c7095381a355a07652b895a1d31376d329a714d3addfb5f6a5848 |
| 4046 | A | 072954 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | WATSON LABS | 30MG | | [] | 1990-09-28 | Sep 28, 1990 | No | No | No | DISCN | WATSON LABORATORIES INC | fe8af8057affcd8bc58343d96123bbb847579909ab8827dd19ec7eb46851fd97 |
| 4047 | A | 072952 | 001 | OXAZEPAM | CAPSULE;ORAL | CAPSULE | ORAL | OXAZEPAM | WATSON LABS TEVA | 10MG | | [] | 1990-09-28 | Sep 28, 1990 | No | No | No | DISCN | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | 147cb3927ba3ed5e460a92fed5ec956a7d7603973ffa7a5271da7cbea0cef4b7 |
| 4048 | N | 019600 | 001 | METHOXSALEN | CAPSULE;ORAL | CAPSULE | ORAL | OXSORALEN-ULTRA | BAUSCH | 10MG | AB | ["AB"] | 1986-10-30 | Oct 30, 1986 | No | Yes | Yes | RX | BAUSCH HEALTH AMERICAS INC | dcf5453d50e190e4569d272a44f876ade6884e4e2e77f336c523081dbb9cfd32 |
| 4049 | A | 060179 | 001 | OXYTETRACYCLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | OXY-KESSO-TETRA | FERRANTE | EQ 250MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | JOHN J FERRANTE | b0bc67afd44c7d9a9c7943baeb779e970fc3c9cf0f07ad223e448812e9ab78e5 |
| 4050 | A | 040199 | 001 | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | OXYCODONE AND ACETAMINOPHEN | ACTAVIS ELIZABETH | 500MG;5MG | | [] | 1998-12-30 | Dec 30, 1998 | No | No | No | DISCN | ACTAVIS ELIZABETH LLC | 555b35272ddd4e4104a760e511bfbcd39096b41baee08e8ea7872bc40b5b5d73 |
| 4051 | A | 040304 | 001 | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | OXYCODONE AND ACETAMINOPHEN | BARR | 500MG;5MG | | [] | 2000-10-02 | Oct 2, 2000 | No | No | No | DISCN | BARR LABORATORIES INC | 4a9bd24bffe50e65fd175d3e73cc306409272a87482f6d3589f000d88b200e80 |